KRYS
Krystal Biotech, Inc.
NASDAQ · USHealthcareBiotechnology
$354.86+3.82%
Price as of Jul 17, 2026
KRYS ownership
Krystal Biotech, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
24
Net (3m)
-$15.9M
Insider trades by month Buys Sells
Jul
Dec
Feb
Mar
May
Jun
Context3-month price +24.6%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 26, 2026 | Thomas John Charlesofficer: EVP, General Counsel | Sell | 1,000 | $347.27 |
| Jun 26, 2026 | Thomas John Charlesofficer: EVP, General Counsel | Option | 1,000 | $179.25 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 2,652 | $310.43 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 589 | $306.33 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 2,039 | $310.94 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 12,729 | $307.81 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 1,348 | $307.09 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 2,784 | $309.49 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 400 | $304.89 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 4,830 | $308.47 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 640 | $302.24 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 320 | $300.75 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 3,803 | $308.89 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 593 | $302.25 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 247 | $303.17 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 544 | $304.81 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 480 | $305.87 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 2,801 | $309.95 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 176 | $303.17 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 240 | $311.65 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 964 | $311.36 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 40 | $312.23 |
| Jun 5, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 320 | $300.75 |
| Jun 5, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 11,461 | $307.68 |
| May 27, 2026 | Thomas John Charlesofficer: EVP, General Counsel | Sell | 642 | $302.03 |
| Mar 6, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 407 | $257.32 |
| Mar 6, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 1,700 | $266.42 |
| Mar 6, 2026 | Krishnan Sumadirector, 10 percent owner, officer: President, R&D | Sell | 1,938 | $262.35 |
| Mar 6, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 920 | $266.56 |
| Mar 6, 2026 | Krishnan Krish Sdirector, 10 percent owner, officer: President and CEO | Sell | 8,798 | $264.85 |
Source: KRYS SEC Form 4 filings, latest Jun 26, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their KRYS positions over the last 6 months (SEC Form 13F).
Increased
260
New positions
167
Reduced
214
Sold out
64
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 4.4M | May 15, 2026 |
| FMR LLC | Increased | 4.3M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 3.9M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 3.9M | Feb 12, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 2.9M | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 2.9M | Mar 16, 2026 |
| VANGUARD GROUP INC | Reduced | 2.8M | Jan 29, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 1.5M | May 8, 2026 |
| STATE STREET CORP | Reduced | 1.3M | Feb 13, 2026 |
| STATE STREET CORP | Reduced | 1.3M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.2M | May 15, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 1.2M | May 14, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Reduced | 941K | Feb 12, 2026 |
| CAPITAL WORLD INVESTORS | Increased | 825K | May 13, 2026 |
| CAPITAL WORLD INVESTORS | Increased | 810K | Feb 11, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.